Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology
Go back to Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology| AXOGEN (NASDAQ: AXGN) | Delayed: 44.74 -0.54 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.28 | 52 Week High | $9.88 | |||
| Open | $44.94 | 52 Week Low | $4.52 | |||
| Day High | $45.66 | P/E | N/A | |||
| Day Low | $44.60 | EPS | $-1.18 | |||
| Volume | 366,053 | |||||

